Whole breast radiotherapy

RADIATION3 trials

Sponsors

Stanford University, National Taiwan University Hospital, UNICANCER

Conditions

Breast CancerBreast Ductal Carcinoma in SituCarcinoma, Ductal

Phase 3

Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ

National Taiwan University HospitalBreast Ductal Carcinoma in Situ

Start: 2019-04-30End: 2025-12-31Target: 810Updated: 2019-08-06

Unknown Phase

Accelerated Partial Breast Irradiation Following Lumpectomy for Breast Cancer

Active, not recruitingNCT00185744

Stanford UniversityBreast Cancer, Carcinoma, Ductal

Start: 2002-09-01End: 2029-03-01Updated: 2026-03-20

Patient's Choice in the Reduction of Their Treatment in Women Over 65 Year With Breast Cancer

CompletedNCT05058196

UNICANCERBreast Cancer

Start: 2021-10-01End: 2025-10-15Updated: 2026-03-30

Related Papers

Radiotherapy versus low-dose tamoxifen following breast-conserving surgery for low-risk and estrogen receptor-positive breast ductal carcinoma in situ: an international open-label randomized non-inferiority trial (TBCC-ARO DCIS Trial)

BMC Cancer2023-09-145 citations

Five-year results of a prospective clinical trial investigating accelerated partial breast irradiation using 3D conformal radiotherapy after lumpectomy for early stage breast cancer.

2016-06-176 citations